Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-24 @ 12:46 PM
NCT ID:
NCT00233961
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of chronic phase chronic myeloid leukemia
* In complete cytogenetic remission, confirmed by bone marrow biopsy within the past month
* Has been receiving imatinib mesylate for ≥ 3 months\* NOTE: \*Imatinib mesylate is held during the study harvesting procedure
* No myelofibrosis on bone marrow ≥ 3+
* Ineligible for or refused allogeneic stem cell transplantation
PATIENT CHARACTERISTICS:
Age
* Over 18
Performance status
* ECOG 0-1
Life expectancy
* Not specified
Hematopoietic
* WBC \> 3,000/mm\^3
* Platelet count \> 100,000/mm\^3
Hepatic
* Adequate hepatic function for stem cell transplantation
Renal
* Adequate renal function for stem cell transplantation
Cardiovascular
* Adequate cardiovascular function for stem cell transplantation
Pulmonary
* Adequate pulmonary function for stem cell transplantation
Other
* HIV negative
PRIOR CONCURRENT THERAPY:
Biologic therapy
* No other concurrent biologic therapy
Chemotherapy
* More than 4 weeks since prior chemotherapy
* No other concurrent chemotherapy
Endocrine therapy
* Not specified
Radiotherapy
* No concurrent radiotherapy
Surgery
* No concurrent surgery
Other
* No other concurrent experimental therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00233961
Study Brief:
Protocol Section:
NCT00233961